Alnylam to Webcast Virtual R&D Day

Cambridge, Business

Malta Closes Funding to Deploy Its Long-Duration Energy Storage System

Cambridge, Business

Vicinity Energy Steams Ahead to Sustainable Future with Arrival of 42MW Electric Boiler in Cambridge, Mass.

Cambridge, Business

Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders USA - English USA - English

Cambridge, Business

A Winter Solstice "Third Thursdays" feat. art/dance/poetry/music curated by harmolodic jazz scholar & practitioner Matt Lavelle

Cambridge

Alnylam Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development for the Treatment of Hypertension in Patients at High Cardiovascular Risk

Cambridge, Business

National Black Pre-Law Conference and Law Fair Connects Aspiring Black Lawyers to Insider Knowledge, Networking, and Resources

Cambridge, Education

The Footwear Collective is launched: To catalyze industry's circularity transformation

Cambridge

Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST

Cambridge, Business

Foundation Medicine Announces Participation in National Cancer Institute's ComboMATCH Initiative to Connect Patients with New Anti-Cancer Drug Combinations

Cambridge, Business

Gestalt and Pramana Announce Availability of Integrated Digital Pathology Solutions and AI-Powered Platform

Cambridge, Business

James Blood Ulmer, one of the "greatest guitarists of all time," followed by a 2nd set feat. D. Bryant, N. Leonard, F. Williams, J. K. Jones

Cambridge

New Research from Foundation Medicine and Roche Demonstrates Improved Outcomes Following Treatment Based on Comprehensive Genomic Profiling in Patients with Cancer of Unknown Primary Origin (CUP)

Cambridge, Business

Alaya.bio Acquires Key Assets From Ixaka France, Accelerating the Progress of Its Novel In Vivo CAR-T Immunotherapy Platform

Cambridge, Business

Nuvalent Announces Pricing of Public Offering of Common Stock

Cambridge, Business

Harmolodic jazzer Dave Bryant announces his Fall "Third Thursdays" lineup, incl. James Blood Ulmer

Cambridge

Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs

Cambridge, Business

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

Cambridge, Business

n-Lorem Foundation Convenes First Annual Nano-rare Patient Colloquium to Share Accomplishments and Learnings in Developing Optimized ASO Therapies for Nano-rare Patients

Cambridge, Business

ARTBIO Announces Appointment of Nick Pullen, Ph.D., as Chief Scientific Officer USA - English USA - English

Cambridge, Business

Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H)

Cambridge, Business